Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001193125-26-034633

Options or other derivatives

  • Chief Executive Officer acquired 1,600,673 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Collard Craig A · Chief Executive Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-01-30 Grant or award : show line 1 in the form Restricted Stock Units +800,337 800,337 D
2026-01-30 Grant or award : show line 2 in the form Performance Stock Units +800,336 800,336 D
Loading xslF345X05/ownership.xml…